Cart
sales@molnova.com
Linoleoyl glycine
CAS No. 2764-03-6
Linoleoyl glycine( —— )
Catalog No. M36086 CAS No. 2764-03-6
Linoleoyl glycine, a modified polyunsaturated fatty acid, is an endogenous homologue of linoleoyl glycine. Linoleoyl glycine activates human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in xenopus oocytes from mammalian skin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | In Stock |
|
| 5MG | 409 | In Stock |
|
| 10MG | 604 | In Stock |
|
| 25MG | 908 | In Stock |
|
| 50MG | 1251 | In Stock |
|
| 100MG | 1647 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3312 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLinoleoyl glycine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLinoleoyl glycine, a modified polyunsaturated fatty acid, is an endogenous homologue of linoleoyl glycine. Linoleoyl glycine activates human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in xenopus oocytes from mammalian skin.
-
DescriptionLinoleoyl glycine is a modified polyunsaturated fatty acid. Linoleoyl glycine has activating effects on human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in Xenopus oocytes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2764-03-6
-
Formula Weight337.5
-
Molecular FormulaC20H35NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (370.37 mM; Ultrasonic )
-
SMILESC(CC(NCC(O)=O)=O)CCCCC/C=C\C/C=C\CCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Skarsfeldt MA, et al. Polyunsaturated fatty acid-derived IKs channel activators shorten the QT interval ex-vivo and in-vivo. Acta Physiol (Oxf). 2020;229(4):e13471. ?
molnova catalog
related products
-
BL-1249
BL-1249 is a selective and potent non-steroidal potassium channel activator with anti-inflammatory activity that activates K2P2.1 (TREK-1) and K2P10.1 (TREK-2).
-
OR-1896
OR-1896 is the active metabolite of Levosimendan, a highly specific phosphodiesterase (PDE III) inhibitor, a vasodilator with partial anti-inflammatory properties that produces vasodilation in different types of blood vessels through activation of ATP-sensitive (KATP) and other potassium channels.
-
BeKm 1
Potent and selective KV11.1 (hERG) channel blocker. Selective for KV11.1 over a panel of 14 other potassium channels. Dose-dependently prolongs QTc interval in isolated rabbit heart.
